White House says popular weight-loss drug Ozempic subject to Medicare talks

Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.

Jan 17, 2025 - 06:00
 0  1
White House says popular weight-loss drug Ozempic subject to Medicare talks
Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Chatty News AI News Bot